Assessing measles vaccine failure in Tianjin, China.
Adolescent
Case-Control Studies
Child
Child, Preschool
China
Disease Outbreaks
/ prevention & control
Epidemiological Monitoring
Female
Humans
Immunization Schedule
Infant
Male
Measles
/ diagnosis
Measles Vaccine
/ administration & dosage
Treatment Failure
Vaccination Coverage
/ statistics & numerical data
Young Adult
China
Measles
Measles-containing vaccine
Tianjin
Vaccine effectiveness
Vaccine failure
Journal
Vaccine
ISSN: 1873-2518
Titre abrégé: Vaccine
Pays: Netherlands
ID NLM: 8406899
Informations de publication
Date de publication:
31 05 2019
31 05 2019
Historique:
received:
05
09
2018
revised:
30
04
2019
accepted:
02
05
2019
pubmed:
13
5
2019
medline:
29
9
2020
entrez:
13
5
2019
Statut:
ppublish
Résumé
Despite increasing global measles vaccination coverage, progress toward measles elimination has slowed in recent years. In China, children receive a measles-containing vaccine (MCV) at 8 months, 18-24 months, and some urban areas offer a third dose at age 4-6 years. However, substantial measles cases in Tianjin, China, occur among individuals who have received multiple MCV doses. This study describes the vaccination history of measles cases 8 months - 19 years old. Data came from measles cases in Tianjin's reportable disease surveillance system (2009-2013), and from a case control study (2011-2015). Twenty-nine percent of those in the surveillance dataset and 54.4% of those in the case series received at least one dose of MCV. The minimum and median time-to-diagnosis since vaccination revealed an increase in time since vaccination for incremental doses. Considerable measles cases in Tianjin occur in vaccinated children, and further research is needed to understand the reasons for vaccine failure.
Identifiants
pubmed: 31078327
pii: S0264-410X(19)30598-5
doi: 10.1016/j.vaccine.2019.05.005
pmc: PMC6800050
mid: NIHMS1052867
pii:
doi:
Substances chimiques
Measles Vaccine
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
3251-3254Subventions
Organisme : NIAID NIH HHS
ID : U01 AI088671
Pays : United States
Informations de copyright
Copyright © 2019 Elsevier Ltd. All rights reserved.
Références
J Infect Dis. 2019 Apr 11;:null
pubmed: 30972418
Public Health. 2017 Oct;151:114-117
pubmed: 28780066
BMC Infect Dis. 2018 Jan 8;18(1):21
pubmed: 29310585
Western Pac Surveill Response J. 2015 Jul 09;6(3):43-50
pubmed: 26668766
Vaccine. 2014 Jun 30;32(31):4001-5
pubmed: 24837773
J Coll Physicians Surg Pak. 2014 Dec;24(12):882-8
pubmed: 25523721
Vaccine. 2015 Nov 17;33(46):6186-91
pubmed: 26469719
J Infect Dis. 2011 Jul;204 Suppl 1:S133-48
pubmed: 21666154
Open Forum Infect Dis. 2016 Mar 24;3(2):ofw064
pubmed: 27186587
Rev Infect Dis. 1983 May-Jun;5(3):506-10
pubmed: 6879006
Biologicals. 1995 Mar;23(1):95-106
pubmed: 7619443
Nat Rev Microbiol. 2006 Dec;4(12):900-8
pubmed: 17088933